A single-center retrospective analysis of childhood hepatoblastoma in China

Wenya Yu1, Xiang Liu2, Jingquan Li1

  • 1School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Gland Surgery
|November 23, 2020
PubMed

Insights

Surgical therapy and male sex impact survival for pediatric hepatoblastoma (HB). Further research into the economic burden of childhood HB is recommended for improved health management.

Area of Science:

  • Pediatric Oncology
  • Health Economics
  • Clinical Management

Background:

  • Investigating critical prognostic factors for pediatric hepatoblastoma (HB) in China.
  • Integrating health economics and management aspects into HB prognosis research.

Purpose of the Study:

  • To identify key factors influencing survival in children diagnosed with hepatoblastoma.
  • To analyze the economic implications and management strategies for pediatric HB.

Main Methods:

  • Retrospective review of 87 pediatric HB cases (2013-2019).
  • Descriptive analysis of patient characteristics.
  • Kaplan-Meier and Cox proportional hazard models for survival and prognostic factor analysis.

Main Results:

  • The 1- and 5-year survival rates for pediatric HB were 87.7% and 78.9%, respectively.
  • Hepatectomy and liver transplantation significantly improved prognosis (HR: 0.039, 0.142).
  • Male sex was associated with a poorer prognosis (HR: 3.614); average medical expenses were 40,217.5 CNY.

Conclusions:

  • Survival rates for pediatric HB in China are comparable to global data.
  • Surgical intervention and patient sex are significant prognostic indicators.
  • The economic burden of pediatric HB warrants further comprehensive investigation.
Abstract